# Diagnostic Accuracy Improvement of an Updated HEART Score to Predict Coronary Artery Disease as Detected by Coronary Computed Tomography Angiography

**Authors:** Michele Della Rocca, Stefano Ferdico, Nicola Cosentino, Alice Bonomi, Andrea Baggiano, Manuela Muratori, Saima Mushtaq, Laura Salvini, Matteo Biroli, Edona Leka, Gianluca Pontone, Marco Grazi, Emilio Assanelli

PMC · DOI: 10.3390/jcm15041424 · Journal of Clinical Medicine · 2026-02-11

## TL;DR

This study improves a tool called the HEART score to better predict heart artery blockages in patients with possible heart issues.

## Contribution

The study enhances the HEART score by adding clinical variables, improving diagnostic accuracy for coronary artery disease.

## Key findings

- The HEART score had a moderate diagnostic accuracy (AUC of 0.68) for predicting significant coronary artery stenosis.
- Adding variables like male gender, right bundle branch block, hemoglobin, and glucose levels improved the AUC to 0.74.
- The updated score showed a 13.5% net reclassification improvement in predicting significant coronary stenosis.

## Abstract

Background: The HEART score is a widely used risk-stratification tool in suspected acute coronary syndrome (ACS), but it still suffers from several limitations. We aim to assess its diagnostic accuracy for predicting coronary computed tomography angiography (CCTA) findings and explore possible enhancement by integrating additional clinical variables. Methods: In this retrospective, observational study, consecutive patients presenting to the Emergency Department with suspected ACS and undergoing CCTA were analyzed. The study assessed the HEART score’s diagnostic accuracy for predicting significant coronary artery stenosis (defined as ≥70% stenosis at CCTA) and explored improvements by integrating additional clinical variables for low-to-moderate-risk patients. Results: Three hundred seventy-nine patients were enrolled (age: 61 ± 15 years; male: 57%). According to the HEART score, 27% were at low risk, 67% moderate risk, and 6% high risk, with a prevalence of significant CAD of 7%, 27%, and 67%, respectively. The area under the curve (AUC) of the HEART score to predict significant CAD was 0.68. Male gender (OR = 1.76, 95% CI 1.03–3.02), right bundle branch block (OR = 4.15, 95% CI 1.66–10.40), and hemoglobin (OR = 1.21) and glucose levels (OR = 1.01) independently predicted significant coronary stenosis at CCTA in patients at low-to-moderate risk. Integrating these variables into the HEART score, the AUC improved from 0.68 to 0.74 (p = 0.004), with a net reclassification improvement of 13.5% (p = 0.032). Conclusions: Integrating additional clinical variables into the HEART score improves its accuracy to predict significant coronary artery stenosis at CCTA in suspected ACS patients at low-to-moderate risk. Tailoring assessments with these variables supports more accurate patient management and highlights the potential for more comprehensive diagnostic approaches.

## Linked entities

- **Diseases:** acute coronary syndrome (MONDO:0005542), coronary artery disease (MONDO:0005010)

## Full-text entities

- **Genes:** NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}
- **Diseases:** cardiovascular death (MESH:D002318), CKD (MESH:D012080), myocardial infarction (MESH:D009203), ischemic (MESH:D002545), atrial fibrillation (MESH:D001281), Right bundle branch block (MESH:D002037), diabetes (MESH:D003920), deep vein thrombosis (MESH:D020246), conduction abnormalities (MESH:D054537), chronic kidney disease (MESH:D051436), inflammation (MESH:D007249), atrial flutter (MESH:D001282), injury to (MESH:D014947), thrombosis (MESH:D013927), repolarization abnormalities (MESH:D000014), platelet aggregation (MESH:D001791), coronary death (MESH:D003643), dyslipidemia (MESH:D050171), hypertension (MESH:D006973), non-obstructive disease (MESH:D001157), left ventricular hypertrophy (MESH:D017379), atherosclerotic (MESH:D050197), ACS (MESH:D054058), luminal stenosis (MESH:D003251), pulmonary thromboembolism (MESH:D011655), coronary calcification (MESH:D003323), coronary artery stenosis (MESH:D023921), DVT (OMIM:612862), ST-segment depression (MESH:D000072657), infarction (MESH:D007238), chest pain (MESH:D002637), COPD (MESH:D029424), cardiac (MESH:D006331), Coronary Artery Disease (MESH:D003324)
- **Chemicals:** Visipaque (MESH:C044834), nitric oxide (MESH:D009569), glucose (MESH:D005947), calcium (MESH:D002118), blood glucose (MESH:D001786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942576/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942576/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942576/full.md

---
Source: https://tomesphere.com/paper/PMC12942576